ChiesiGrouptoAcquireKalVistaPharmaceuticals,ExpandingitsGlobalRareDiseasePortfolio
===2026/5/7 17:20:20===
ditary angioedema, strengthening Chiesi’s long-term commitment to people living with rare conditions Transaction expected to close in Q3 2026
=*=*=*=*=*=
当前为第21/21页
上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页